Allosteric modulators for
human health
About us
Addex Corporate Presentation
Overview
Our people
Executive Officers
Non-Executive Directors
Contact
Privacy Policy
Careers
Pipeline
Clinical and Pre-Clinical Pipeline
Research And Development
Technology
Allosteric modulation
Publications
Partners & collaboration
Investors
Addex Corporate Presentation
Stock Data
Press releases
Ad hoc announcements (Art. 53 L.R)
Events
Financial Reports
Analyst Reports
General Meetings
SEC / SIX Filings
Guide to US ADSS for Six Shareholders
Register for email news
Corporate Governance
Contact
Media
Press releases
Contact
Press releases
All Years
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
Please select year
05.05
2021
Addex Reports Q1 2021 Financial Results and Provides Corporate Update
05.03
2021
Addex Therapeutics to Release Q1 2021 Financial Results and Host Conference Call on May 5, 2021
04.26
2021
Addex Increases Issued Share Capital to Create Treasury Shares
04.26
2021
Addex to Participate at the 4ᵗʰ Annual Neuroscience Innovation Forum
04.13
2021
Addex to Present at the 20th Annual Needham Virtual Healthcare Conference
04.08
2021
Addex Files Registration Statement on Form F-3 with the US Securities and Exchange Commission
03.11
2021
Addex Reports Full Year 2020 Financial Results and Provides Corporate Update
03.09
2021
Addex Therapeutics to Release Full-Year 2020 Financial Results and Host Conference Call on March 11, 2021
03.04
2021
Addex to Present at the H.C. Wainwright Global Life Sciences Conference
02.17
2021
Addex Provides Trading Update and Completes 2020 with Strong Cash Position of CHF18.7 million
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
Next
Back